Ensign Group Inc.

ENSG
Financial Analysis · Updated May 29, 2026 · Coverage 2026-Q2
Latest Q Revenue
$1.4B
Q1 2026 · +18.4% YoY · Beat consensus by 3.7%
TTM ROIC
12.7%
FY2025 · NOPAT / Invested Capital (Financial Capital Only, Ex-Leases): NOPAT = Operating Income × (1 - 27% tax rate); Invested Capital = Total Equity + Financial Debt - Cash · WACC ~7.5% · Moat spread +5.2pp
Margin Profile
Operating 8.4%
FCF 5.6%
FY2025
Net Cash
$360M
Cash $504M · Debt $144M · FY2025
Diluted Shares
58M
FY2025 · +1.2% (dilution)

Business Overview


source: coverage-next-full ticker: ENSG step: "01" title: Business Overview — What Ensign Group Does created: 2026-05-29

ENSG — Business Overview

Company Summary

Ensign Group, Inc. is the leading publicly traded skilled nursing facility (SNF) operator in the United States, with a portfolio of 378 operations across 17 states as of Q1 2026. Founded in 1999 and headquartered in San Juan Capistrano, California, the company has built its franchise through disciplined acquisition of underperforming facilities, operational turnaround, and an exceptionally decentralized management culture.

Ensign's business model is simple in concept and difficult in execution: acquire distressed or underperforming SNFs and senior living communities at below-replacement-cost valuations, install local leadership with full P&L accountability, and drive occupancy, quality ratings, and reimbursement improvement over a 24–48 month time horizon. The company has executed this model for 25+ years with remarkable consistency, compounding revenue at approximately 16% annually while generating above-peer margins and quality outcomes.

Operating Segments

Skilled Nursing Facilities (Primary — ~85% of Revenue)
  • Core product: post-acute short-stay rehabilitation (Medicare, managed care) and long-term custodial care (Medicaid)
  • Serves patients discharged from hospitals needing continued clinical care, physical/occupational/speech therapy
  • Key metrics tracked: occupancy rate, payer mix (Medicare vs. Medicaid vs. managed care), CMS star ratings, staffing ratios
  • As of Q1 2026: 331 skilled nursing operations (after subtracting 47 senior living), across 17 states
  • Largest states: California, Texas, Arizona, Colorado, Utah, Idaho, Washington, Nevada
Senior Living / Assisted Living Communities (Secondary — ~15% of Revenue)
  • 47 senior living operations as of Q1 2026
  • Serves elderly residents who need personal care assistance but not intensive medical/rehabilitative services
  • Revenue from private pay and state Medicaid waiver programs
  • Lower-acuity, lower-margin than skilled nursing; Ensign treats this as complementary to its SNF portfolio
Standard Bearer Healthcare REIT, Inc. (Internal REIT Subsidiary)
  • Not a separate operating segment for revenue purposes
  • Owns approximately 160 real estate assets (SNF and senior living buildings) that are leased back to Ensign operating subsidiaries
  • Inter-company leases are eliminated on consolidation
  • Ensign has used this structure to monetize real estate assets at scale while maintaining operating control
  • Standard Bearer provides Ensign a path to raise capital via REIT mechanics (e.g., sale-leaseback, external REIT spin-off optionality)

Geographic Footprint (as of Q1 2026)

State Approximate # of Operations
California ~80–90
Texas ~40–50
Arizona ~30–40
Colorado ~25–35
Utah ~25–30
Idaho ~20–25
Washington ~15–20
Nevada ~10–15
Other (MT, WY, ND, SD, KS, NE, IN, FL) Balance

Expansion States (recent entry): Florida, Indiana, Kansas, Nebraska — acquired operations 2024–2026

Business Model Mechanics

Revenue Generation
  1. Medicare (FFS): Highest-margin payer; short-stay rehab patients (avg stay 20–30 days); rate set annually by CMS under PDPM
  2. Medicaid: Largest volume payer; long-term custodial patients; state-set rates; lower margin than Medicare
  3. Managed Care / Medicare Advantage: Growing payer; rates negotiated annually with insurers; margin between Medicare FFS and Medicaid
  4. Private Pay: Smallest share; premium pricing for self-pay patients in high-quality facilities
Acquisition-Driven Growth Engine
  • Ensign acquires 40–60 facilities per year at valuations typically at or below replacement cost
  • Acquired facilities typically start at 65–70% occupancy; Ensign targets 80%+ within 18–24 months
  • Acquisition financing: internal cash generation + revolving credit facility; minimal leverage by design
  • Each acquired facility operates as an independent entity with local "operator" leader accountable for financial and quality outcomes
Decentralized Operating Model
  • Unlike centralized chains (Genesis, Kindred), each Ensign facility has its own administrator, DNS (Director of Nursing Services), and local leadership
  • Local operators receive equity participation in their facility's performance (phantom equity / incentive arrangements)
  • Corporate provides capital, compliance, clinical resources, and cultural framework; does NOT run day-to-day operations
  • This model creates accountability at the point of care, reduces bureaucracy, and enables rapid cultural integration post-acquisition

Founding Philosophy & Culture

  • Christopher Christensen (founder) built Ensign around an explicit values framework: "ignite human potential"; culture of servant leadership and operational excellence
  • "The Ensign Way" — documented cultural standards that define how facilities should behave
  • Culture is central to recruitment/retention, which is a critical differentiator in labor-constrained post-acute care
  • Culture also embeds compliance rigor — critical in an industry under continuous regulatory and litigation scrutiny

Recent Operational Scale (Q1 2026)

Metric Value
Total Operations 378
States 17
Skilled Nursing Beds (approx.) ~38,000–42,000
Senior Living Communities 47
Standard Bearer Owned Properties ~160
4/5-Star CMS Rated Facilities 153 (19% above peer avg)
Q1 2026 Revenue $1,389.2M
Q1 2026 Adj. EPS $1.85
Same-Facility Occupancy (Q1 2026) 84.3%

Financial Snapshot


source: coverage-next-full ticker: ENSG step: "04" title: Financial Snapshot — 3-Year P&L Summary created: 2026-05-29

ENSG — Financial Snapshot (3-Year P&L Summary)

Annual Income Statement (USD millions)

Metric FY2022 FY2023 FY2024 FY2025
Revenue $3,025.5 $3,729.4 $4,260.5 $5,057.8
Revenue Growth +15.1% +23.3% +14.2% +18.7%
Operating Income $296.8 $255.4 $358.3 $425.3
Operating Margin 9.8% 6.8% 8.4% 8.4%
Net Income $224.7 $209.4 $298.0 $344.0
Net Margin 7.4% 5.6% 7.0% 6.8%
EPS (Diluted) $3.95 $3.65 $5.12 $5.84
SBC $30.8 $36.2 $48.3
Shares (Diluted) ~55.8M 56.6M 57.4M 58.1M

Key Ratios and Margin Analysis

Operating Margin Discussion
  • FY2022 (9.8%) was temporarily elevated by residual COVID-era Medicare add-on payments phasing out
  • FY2023 (6.8%) reflects transition: accelerated acquisition activity (heavy ramp costs) + COVID subsidy fadeout + elevated labor costs in the post-COVID normalization period
  • FY2024–FY2025 (8.4%) represents normalized operating margin range; management targets continued improvement as acquired facilities mature
  • EBITDA margin: estimated ~10–12% (adding ~$120–160M D&A to operating income); within top tier for SNF operators
Net Margin Discussion
  • FY2023 dip (5.6% → 7.0% recovery in FY2024) reflects the $47.3M DOJ settlement impact recorded in 2023 operating results
  • Clean net margin of 7–8% is high quality for post-acute care services (capital-light lease model with most properties rented)
  • Tax rate approximately 27–28% in recent years (standard corporate rate)

Adjusted EPS vs. GAAP EPS

Year GAAP EPS Adj. EPS Key Adjustments
FY2023 $3.65 est. ~$4.20 DOJ settlement, SBC, amortization
FY2024 $5.12 est. ~$5.70 SBC, amortization of lease adjustments
FY2025 $5.84 $6.57 SBC ($48.3M), amortization, lease adjustments
Q1 2026 $1.67 $1.85 SBC, amortization

The ~10–12% gap between GAAP and adjusted EPS is primarily SBC ($48.3M in FY2025, ~$0.83/share diluted). The SBC level (~1% of revenue) is not alarming given the company's size but is rising in absolute terms as management/employee equity plans scale.

Balance Sheet Summary (Year-End)

Metric FY2023 FY2024 FY2025
Total Assets $4,177.5M $4,669.4M $5,463.0M
Cash & Equivalents $509.6M $464.6M $503.9M
PP&E (Net) $1,090.8M $1,291.4M $1,696.9M
Operating Lease ROU Asset $1,756.4M $1,861.1M $2,097.9M
Goodwill $76.9M $98.0M $98.0M
Long-Term Debt $152.4M $148.4M $144.4M
Operating Lease Liability $2,064.0M
Total Equity $1,491.9M $1,837.1M $2,231.7M

Leverage and Capital Structure

  • Financial debt is minimal: $144.4M LT debt on $5.06B revenue — essentially debt-free on traditional metrics
  • Operating lease liabilities ($2.06B) represent SNF facility leases — standard for an operator that rents most of its buildings
  • Net cash (ex-leases): Cash $503.9M minus LT debt $144.4M = ~$360M net cash
  • Credit facility: Ensign maintains a revolving credit facility for acquisition financing; historically drawn minimally
  • Ensign's balance sheet is clean relative to most SNF peers, who often carry sale-leaseback obligations and significant senior secured debt

Cash Flow Statement Summary

Metric FY2023 FY2024 FY2025
Operating Cash Flow $376.7M $347.2M $564.3M
Investing Cash Flow -$182.7M -$390.1M -$513.2M
Financing Cash Flow -$0.6M -$2.2M -$11.8M
Net Change in Cash +$193.4M -$45.0M +$39.3M
Estimated Capex ~$130M ~$160M ~$280M
Estimated Free Cash Flow ~$247M ~$187M ~$284M

Key observations:

  • FY2025 operating CF surge to $564.3M (+62.5%) reflects earnings growth + working capital improvements
  • FY2024 investing outflow (-$390.1M) signals accelerated acquisition activity (51 deals in 2025 partly funded in 2024)
  • Financing cash flows minimal — ENSG does not rely on equity issuance or debt funding for growth
  • FCF conversion: ~80–85% of net income (high quality, limited capex requirement for lease-based operators)

Key Financial Quality Indicators

Indicator Assessment
Revenue Growth Consistency Excellent (15–23% annually, 5yr CAGR ~16%)
Margin Trend Stable-improving (6.8%→8.4% op margin over 2023–2025)
Balance Sheet Clean (minimal debt, growing equity)
Cash Flow Quality High (FCF/NI ~80%+, no working capital issues)
EPS Growth Strong ($3.65 → $5.84 in 2 years = +60%)
Dividend Token ($0.25/share; ~0.15% yield at current price)
Capital Return Modest (minimal buybacks; acquisitions prioritized)

FY2026 Financial Outlook

Metric FY2026 Guidance FY2025 Actual Growth
Revenue $5.81–$5.86B $5.06B +15%
GAAP EPS $7.48–$7.62 $5.84 +28%
Adj. EPS ~$8.30–$8.45 $6.57 +27%

Q1 2026 actuals ($1,389M revenue / $1.85 adj. EPS) are running ahead of the implied quarterly pace embedded in guidance, suggesting guidance may be conservative. Management has a 5+ year history of beating their own guidance by ~3–7%.

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $ENSG.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/ENSG/fundamental$1.00 · Bearer token required
Markdown: /stocks/ensg/financials/md · → thesis · → memo